Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Humacyte (HUMA) FCF Margin (2025)

Humacyte has reported FCF Margin over the past 1 years, most recently at 5597.22% for Q4 2025.

  • Quarterly results put FCF Margin at 5597.22% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 5195.49% (changed N/A YoY), and the annual figure for FY2025 was 5195.49%, changed.
  • FCF Margin for Q4 2025 was 5597.22% at Humacyte, down from 3180.48% in the prior quarter.
  • Over the last five years, FCF Margin for HUMA hit a ceiling of 3180.48% in Q3 2025 and a floor of 8854.15% in Q2 2025.